Latest / Newcomer Pod / From Deus Ex Medicina: Vinod Khosla, Bob Kocher & Annie Lamont
Transcript
- 0:00Hey, welcome to the Newcomer podcast.
- 0:02It's Eric. Newcomer here.
- 0:03I'm fresh off Daegu sex Medicina.
- 0:05I think I'm literally wearing the same sweater I wore to Daegu
- 0:08sex medicina. I promised I'd change my
- 0:10clothes, but I, you know, you get attached to a sweater and
- 0:14then I wear it to death. Anyway, Yeah, it was a great
- 0:16event. This was our inaugural AI Health
- 0:19and Longevity Summit. We brought together, you know,
- 0:22some 200 people in San Francisco, heavy mix of
- 0:26founders, investors, members of the media, other health insiders
- 0:30to talk about 3 big themes rising in health right now.
- 0:34One obviously foundation models in the rise of generative
- 0:37artificial intelligence, which is powering companies like a
- 0:41bridge, which is doing doctor note taking and open evidence
- 0:44which is helping doctors diagnose patients.
- 0:47Both companies had their Co founders speak at daew sex
- 0:50medicina. Second, we had the longevity
- 0:53trend with GLP ones, you know, suddenly making everybody
- 0:58commit. So helping healthy people.
- 1:00There's a lot of money to be made there, a lot of value to be
- 1:02created for patients. We had the Co founder of Noom
- 1:06Seiju, who you know, whose company is doing, I think micro
- 1:09dosing GLP. We had Celine, the cofounder and
- 1:14CEO of loyal who is helping dogs live longer and always very
- 1:21thoughtful speaker our longevity.
- 1:22So we had that longevity theme. And then third, there's all the
- 1:25insanity with Maha, you know, make America healthy again, RFK
- 1:30and the Trump administration's changes to health care.
- 1:33So how is that sort of an inflection point for good and
- 1:36bad? And there was definitely some
- 1:37soul searching of whether, you know, the traditional
- 1:41Republicans were helping Medicare Advantage as much as
- 1:43some investors had thought Democrats like to beat up on
- 1:46Medicare Advantage. And now Trump hasn't come in and
- 1:49saved the day either. And that's obviously been an
- 1:51exciting area of investment. So those were three big themes.
- 1:54Other themes, you know, took us by surprise.
- 1:56Chai's ability to do drug trials much more effectively than US
- 1:59certainly stood out. And then I think the final,
- 2:03final theme I'd flag before kicking this over would just be,
- 2:06you know, continued hopes that patients will be buyers of
- 2:09healthcare sort of directly. And you know, we had the CEO of
- 2:12Function Health speak who's selling diagnostic tests to
- 2:15consumers and we had some healthy debate over whether
- 2:20consumers would prefer only to use their insurance company or
- 2:23not. Anyway, those are my high level
- 2:25takes. We picked two of our favorite
- 2:28panels to share on here in the podcast feed.
- 2:31First, my conversation with Bob Kosher at Fenrock and Annie
- 2:36Lamont at Oak HTFT, 2 of the top health investors.
- 2:41And then the second is me with Naima Raza, who I Co hosted
- 2:46daily sex medicine. Yeah, we interviewed the ever
- 2:48spicy Vinod Khosla and I wanted to share the investor
- 2:52conversations because I do think they zoom out the farthest you
- 2:55get the greatest scope of what we really covered in the day.
- 2:58We're going to post a lot, if not all of the other talks on
- 3:02our YouTube channel. So go check out Newcomer Media's
- 3:05YouTube channel. You can always go to the sub
- 3:08stack newcomer.co to get routed to our stuff.
- 3:11So go watch the videos there. But I think this conversation
- 3:14with Bob and Annie and then my conversation with Naima and
- 3:17Vinod really helped sum up some of the big questions of the day.
- 3:21So without further ado, give them a listen.
- 3:26Investors that I really trust, both in terms of having a good
- 3:30sense on policy and having good values and then being very
- 3:34serious about like the businesses you invest in.
- 3:36So say to talk about it all. And obviously this is still a
- 3:39technology business at the end of the day.
- 3:41So the changes in technology willpower, everything you're
- 3:43doing. I just want to start off, you
- 3:45know, we're talking about healthy businesses.
- 3:48What what are some startups earlier stage businesses where
- 3:51you think this is not like a long bet on like the technology
- 3:55coming together, You feel like they've got a great business
- 3:57model? Like where are areas right now
- 3:59you're excited about like business model types in
- 4:02startups? Annie, you want to go first.
- 4:05Sure. So look it, it doesn't matter if
- 4:08it's healthcare, fintech technology, I mean the best
- 4:11business model out there is SAS software.
- 4:14Wait works over and. Over again and.
- 4:17That's over here. It's dead.
- 4:19It was software and back, you know, I mean, I think that's
- 4:22what's really interesting. So I I2 parts to this question,
- 4:25right And the answer is that SAS software anytime, anywhere, you
- 4:30know, if I can find that and we we were both in Athena way back
- 4:35and that's a version that's like a 70% because it's SAS software
- 4:39enabled service really. But SAS if you can get 8090%
- 4:43margins, you know, like great. And I feel like we're back there
- 4:46in terms of being able to sell software to providers and health
- 4:51systems where, you know, EHR has effectively scooped up all of
- 4:55those dollars, you know, for the last 20 years and now they're on
- 4:58for business. But I think the the other part
- 5:01is impact. And I think Bob and I are both
- 5:03in this for impact. And so I think you know, like
- 5:07you just had Prashant from Aikido, one of our companies and
- 5:12that's impact, you know, like embedding obviously AAI with
- 5:17interior delivery, you know, like see the impact, you know,
- 5:19love that. We just sold the company called
- 5:22Care Bridge. And you know, if you, if you
- 5:25actually looked at that model, that was the dual eligibles LTSS
- 5:29in the home where you were taking risk on them.
- 5:31But the first part of the business was the wedge and that
- 5:34was they became the standard for evaluating how what kind of
- 5:39caregiver should be in your home and for how many hours.
- 5:43And if you can believe it, there's literally no standard in
- 5:45America for that. And so they created a standard
- 5:48and algorithms rounded and support and and that's really
- 5:51what health plans first bought. And then I took that wedge into
- 5:54taking risk on all of those patients.
- 5:56So you know, to me, impact matters.
- 5:59Bob, you have businesses that are making you salivate right
- 6:01now. Absolutely.
- 6:02But first, thank you Eric and Iema for bringing us together.
- 6:05This is super cool and I love that you taught us some Latin.
- 6:09Yeah, I checked it. I actually did.
- 6:11I have a, you know, my wonkiest friend from college who's like a
- 6:14classics professor. I did call him up and made sure
- 6:17that it was like somewhat coherent as a name in lat.
- 6:20So it was a it was blessed. I'm glad I took linguistics.
- 6:24It's a good thing. And I'm a zoologist first to any
- 6:29Yeah, that matters. That's why we do this job.
- 6:31We could be SAS investors and that would suck.
- 6:35Helping do eligible people with better is, is like what we
- 6:38actually want to do. I think 3 things to find a good
- 6:41business model. And once it's happened to me,
- 6:44the first one is get paid upfront, a lot of money.
- 6:47Most healthcare business that I'm involved with and see don't
- 6:50get paid a lot upfront. They get paid later and not
- 6:53enough. And then you're like hoping to
- 6:54make it up on value later. And then cash.
- 6:57Cash is king. And having it first is really
- 6:59good #1 #2 is software. Software has a lot better
- 7:03margins and you can do a lot more when you have more margin
- 7:05and then #3 is have very long contracts, just hard to do in
- 7:09the US but the best business I'm involved with from a business
- 7:12model perspective is 1 called me.
- 7:14I knew you were going to say that.
- 7:15I was like, yeah, yeah, I have a friend.
- 7:16New work there. Yeah, yeah, yeah.
- 7:17And as a company, we started in Korea.
- 7:19You know. In Korea, people buy 20 year
- 7:22insurance policies and they can't get out of them and so
- 7:25we're attached on Day 1 and in 20 years they need you.
- 7:28And so you get paid for 19 years before they need the service.
- 7:30And so that's gets you all the cash up front and then you do
- 7:33the thing and it's supposed to software.
- 7:35And so one thing we should do in the US to really improve
- 7:37preventative care and make everybody's life easier is to
- 7:39have multi year insurance models.
- 7:41The idea that you can switch every year means that you can't
- 7:43have no time for ROI. And so I hope that that's
- 7:46something that comes out is a multi year policy because then
- 7:49you can do a bunch of the stuff that we all want to do and have
- 7:52an ROI period that works. Yeah, we couldn't have a sort of
- 7:55AI oriented event without asking about the investability of like
- 7:59foundation model startups. Like what is your view on, you
- 8:03know, rapper companies, companies that are competing
- 8:06directly against open AI and Anthropic?
- 8:09Like how much have you been enticed to invest in businesses?
- 8:12They're spending a lot of energy building their own models.
- 8:15And how much have you been wary or not of businesses that rely
- 8:18on open AI and others? It's a big question.
- 8:24Big question. I can make him go first.
- 8:25You had to go first on the 1st. I I think competing with opening
- 8:28against the foundation models is crazy.
- 8:30Don't do it and I wouldn't do it.
- 8:32All of our companies are using AI inside to make the product
- 8:35better, the margins higher and the last panel talked about the
- 8:39need to have multiple models and switching across them.
- 8:42I think the multiple models work awesome and you can switch
- 8:44across them and it seems like you can train them pretty
- 8:46quickly to do almost everything you want to do.
- 8:49And so I wouldn't want to be against that, right?
- 8:51I think about AI making my ideas to serve patients just a lot
- 8:55more scalable, a lot more profitable, a lot more
- 8:56effective. I mean, you can listen to
- 8:59elderly people who are lonely and make them feel better.
- 9:01You can do every language now. You can tailor the care model or
- 9:05the dietary recommendations to any kind of diet.
- 9:08So it it makes everything better.
- 9:11You just you agree with that or. I, I agree with that.
- 9:14And I think the reality is it's a, it's a safer place to, to, to
- 9:18play in the sense that they're not going to do the last mile.
- 9:22I mean, they might do it. If you think about drug
- 9:24discovery, I actually think they're going to be working on
- 9:26models that'll be, that will effectively compete with those
- 9:31that are working in drugs, drug discovery companies.
- 9:33But I also think they will partner with pharma and with
- 9:36biotech companies and, and, and, but they will be closer to the
- 9:40product creation and probably in a way of royalties and some of
- 9:45the classic companies right now they're doing drug just drug
- 9:47discovery. But I think in, you know,
- 9:50healthcare service, it's just hard, you know, like, I mean, if
- 9:53you, if you actually looked at the volumes at open AI, I mean,
- 9:56the reality is, is it's the tools, right, Developer tools
- 9:59off the chart using it. And then you, you know, you do
- 10:03have the, you know, the ambiences that are bridges and
- 10:06health care that are like got, you know, real volumes and then
- 10:09sort of, you know, everything else falls off.
- 10:12I think the reality and drug discovery actually doesn't
- 10:14create much traffic models. But so, you know, I think the
- 10:20reality is, is that that last mile is really hard.
- 10:23They're not going to want to do it from a go to market motion
- 10:26from the actually understanding the edge cases.
- 10:28I mean, they can. They can.
- 10:30And this is the risk you're saying the reason open AI might
- 10:33not fully embrace it is it's just like.
- 10:35The Guard. The Guard house here.
- 10:37Sort of a no. It's just like, yeah, how
- 10:39quickly you can like scale these things.
- 10:40Yeah, right. Like when you have.
- 10:42Some coding coming out of you. It's like, oh, this is great.
- 10:44Like let's do that. Yeah, let's do that.
- 10:46What I want to ask the audience, honestly just straightforward AI
- 10:50in health, over hyped, under hyped.
- 10:55Just like let's I let's get the pulse on the road over hyped
- 10:58under hyped AI in health, all right.
- 11:00Who is? Over hyped.
- 11:04Wow, we've got. Who's the most optimistic crowd
- 11:07ever? Very not dated or skeptical.
- 11:10Under hyped. Yeah, it's like everyone is
- 11:15still a true believer. No one has.
- 11:16Gotten it off. Yeah, yeah, it's good.
- 11:19To learn early crowded I. Think the reality is both things
- 11:22can be true, right? I mean, I think the reality is,
- 11:25is there 800 companies that have been funded the last three years
- 11:28and, you know, doing AI and healthcare.
- 11:30And the reality is, is that some subset of those just like Google
- 11:35and Amazon, you know, came out of 2000 and a mania there.
- 11:38I mean this is a mania and valuations are going to be like
- 11:41way beyond for every company, but probably what they should
- 11:44be. But that except for that topic
- 11:48we bet in. A bunch of businesses and then
- 11:49some of them are exactly. It's the nature of intra
- 11:51business. I think that I think it's such
- 11:53an extraordinary moment, like I've never seen a moment of my
- 11:5630 years in healthcare where we're actually going to make a
- 11:58difference. We're actually going to, we are
- 12:00actually going to lower costs. We are actually going to make
- 12:02providers and clinicians lives better and patients lives
- 12:04better. So I think it's worth it.
- 12:07And I also think it's, you know, you're going to have the top 5%
- 12:11of companies are going to be amazing, you know, and then
- 12:14you're going to have probably well, probably well, I'll
- 12:16probably get lucky in some like points point solution companies
- 12:20that you know, we sell them. You know, they'll probably be, I
- 12:22don't know, couple 100 companies sold and then you know, they're
- 12:25going to be the other 600 of 1000 that have been created, you
- 12:28know, Walking Dead like you don't think usual moving.
- 12:31On to sort of a new some companies die in start-ups,
- 12:35spoiler alert, the Bob the GOP ones and just sort of like
- 12:40change the longevity conversation.
- 12:42Like, you know, this, this idea like treating longevity means a
- 12:46lot of things to different people.
- 12:47It's obviously sort of an amorphous word.
- 12:49I mean, some of it has been like, oh, let's think outside
- 12:51the medical system. Some of it to people, I think is
- 12:54like individualized care. Some of it's treating healthy
- 12:57people. But like what to you has been
- 12:59the lesson from GLP ones? And like how are using it change
- 13:02with startups you're you're looking at I mean.
- 13:05They're the greatest medicines I've ever seen, I think, except
- 13:07for cancer drugs. As a doctor, there's so many
- 13:11patients I've spoken to about, you know, how to be healthier or
- 13:14lose weight, change their diets. And for some people, no matter
- 13:18what they try, it doesn't work. And then you give them a GLP 1
- 13:21and it works awesome and everything gets better.
- 13:23Their cardiovascular risk, their cancer risk, their energy that
- 13:26have to diabetes go the way and the prices for these drugs are
- 13:29falling to the point that they're going to become widely
- 13:31accessible to people and orals are coming soon.
- 13:33And so this is a revolution that they can in health for people on
- 13:37earth. And I hope that they're more
- 13:39accessible to more people faster.
- 13:40At the end of the day, I think pairing it with lifestyle
- 13:43changes and an aura ring and sleep and stuff makes them
- 13:45better. So I hope people do that too and
- 13:47don't just take them and then like, eat McDonald's.
- 13:50But I think. That we're at the beginning of a
- 13:53lot of biological insights are ran out of live longer,
- 13:56healthier and better. But the key thing is years of
- 13:58like health that you can do things where you're alive and
- 14:01well. And I'm very hopeful that we're
- 14:03going to have a bunch of improvements in our joints and
- 14:06in our weight and in our metabolic health and in our
- 14:08cancer care to help us a little longer.
- 14:10And I think the next 10 years are going to be actually a kind
- 14:13of like there'll be a wave of longevity type things that
- 14:15really work. And I think about this from the
- 14:18Medicare management insurance. Andy and I are together at
- 14:20Devoted Health and we think about or devoted, how do we
- 14:22improve with the lifespan and health of our patients and do
- 14:25cost effectively and GOP ones are now becoming part of the
- 14:27cost effective approach to doing that.
- 14:29Yeah. But it.
- 14:31Goes back to you're actually saying you need to actually own
- 14:34as an insurer, you need to own the life you know long enough to
- 14:37actually pay for it. I got devoted.
- 14:39We keep them over more than five years and so we can do a lot of
- 14:41things about their health and well-being, investing.
- 14:43But you can't. Do in a commercial plan with us
- 14:45which every year for sure. Yeah, have.
- 14:47They changed your philosophy on investing or the success of GOP
- 14:51ones? No, not.
- 14:54Not really. I meant to think the reality is
- 14:57is I think there's intelligent I mean we're in Noom, you know,
- 15:00that's that's certainly part of their offering.
- 15:03And I think when they absolutely makes an impact from people's
- 15:06health and make it more available through compounded
- 15:08drugs. But I think the whole area of
- 15:11longevity other than frankly GLP ones is is that is over hyped.
- 15:16You know, that isn't you know, like the I mean you may have
- 15:20function health speaking today. And then I think the reality is
- 15:2390% of the tests that they do can be reimbursed, you know, by
- 15:26if you go to your doctor, you know.
- 15:28Oh, good. Well, I'm yeah, well, I'm there.
- 15:31But our GOP ones I. Think the the big idea and
- 15:34there's data from a couple companies, Amata and Bruta being
- 15:37the two that I've seen the most data on Bruta were investors in
- 15:40is that you can get people off of them and keep the weight off.
- 15:42So what I love about GOP ones is that anybody who takes them will
- 15:45lose weight. And then that's the moment that
- 15:48you say, let's change your diet because you're not hungry when
- 15:50you're on GOP 1. So I can then change your diet
- 15:51around. I can teach you how to eat a
- 15:53healthier, lower carbohydrate diet that makes you feel good
- 15:58and then get you off of the medicine and keep the weight
- 16:00off. He is keeping the weight off and
- 16:01not bouncing back and not taking it forever because we're not
- 16:05sure actually taking them forever at the doses of GLP, 1
- 16:08weight loss doses is a good idea.
- 16:10But for sure for a year to get you to where you should be, it's
- 16:13a good idea. And if you keep the weight off,
- 16:14then it's that's the best thing. And it's like you see a lot of
- 16:17people doing that and then it's very cost effective.
- 16:20You know, like. Cutting edge medicine I get, you
- 16:22know, or like, you know, I'm taking with Govi.
- 16:25My wife did a bracha cancer screening.
- 16:28But those are still like medical establishment provided things.
- 16:33Do you think there are things that like the Silicon Valley
- 16:35connected type is doing in terms like buying their own tests that
- 16:39you're like, yeah, Oh my God. When your rich friend.
- 16:41'S calling you and you're like, you're a doctor and you know
- 16:42everybody my. Rich friends call me.
- 16:44I say, what the fuck are you doing?
- 16:46You're like, go to a. Doctor, you're like, don't
- 16:47ingest the stuff or is there anything You're like, oh, there,
- 16:49that's a good one. You should you should do that.
- 16:52Oh my. God alright, you're asking for
- 16:55non evidence based things. Literally a good.
- 16:57Idea to say in public, Yeah. A lot.
- 17:00A lot of people. That metformin probably is a
- 17:03good idea for most people would say if it's impactive and it
- 17:05makes you live longer, maybe erythromycin is good for your
- 17:08joints. I don't know, but there's much
- 17:10people who think it is maybe. And then we get down the path of
- 17:14supplements and I don't know, people feel better on magnesium.
- 17:16So that's probably good, but I don't know.
- 17:18But you're. Wary.
- 17:19I don't know. Lithium.
- 17:20I mean, yeah, they gave out this study on lithium this week,
- 17:24actually, where improves your memory and may reduce dementia,
- 17:27induce locks, plaque. I'm like, OK, we can go to the
- 17:30CVS and get that right in here. The.
- 17:34Moving on to sort of a, the policy conversation, I mean,
- 17:37both of you, I think we're excited, you know, a potential
- 17:40upside of a Republican administration with that they
- 17:42would embrace Medicare Advantage.
- 17:44Have you, have you seen that what you read specifically on
- 17:47Medicare Advantage? And then I'll ask more broadly
- 17:49what your reaction to sort of the Trump health policy has
- 17:52been. All right, Henny, Annie, you're,
- 17:54you're up. You're.
- 17:55Up. OK.
- 17:57So yeah, you know, like. Weirdly, both Trump
- 17:59administrations have had a number of my CEOs actually
- 18:03involved and they've been, I would say, much more
- 18:06constructive than the Biden administration, unfortunately,
- 18:10in healthcare. So I would say there are two
- 18:11things. I mean, obviously Medicaid is
- 18:13actually, you know, the one that people are most worried about
- 18:17and the obviously the subsidization of the exchanges.
- 18:23My biggest fear is actually the the exchanges go away because
- 18:25you don't do the subsidies, you know, people.
- 18:28Then it you know, the cost of the exchange going being on the
- 18:31exchange goes up so much. The people, just the healthy
- 18:33people just get off it. They're not going to pay,
- 18:35basically. Medicaid funding has been cut
- 18:37because of worker tests, yes. Worker testing, you know.
- 18:42And then if they don't have that money flowing in, well and then.
- 18:44And but, but also, what about the?
- 18:46Changes because there's still all the people under the ACA.
- 18:49He will be subsidized on the exchange going to be about 2
- 18:51million people from the subsidies expiration.
- 18:53The 22 million will stay. So there's enough healthy people
- 18:56there. Why does?
- 18:57I, you know, I can only talk from one state, but we, we're
- 18:59down to like 1 insurer willing to, to be in that.
- 19:02Well, that's the. Question is, is it exciting for
- 19:04insurance? Yeah.
- 19:05Does it does it make sense for insurers, because you're going
- 19:07to, I think of the risk of that population, you have a less
- 19:10healthy population. And then in those exchanges and
- 19:13on the MA side, I, you know, I think it, it's interesting
- 19:17because I think Republicans and Democrats, like if you obviously
- 19:20that's one, that's one of my CE OS said Republicans have now
- 19:23become Democrats, or at least the base that's supporting it.
- 19:25You know, the base that was supporting Democrats now
- 19:27supporting Republicans, Republicans now supporting
- 19:29Democrats. So what does that mean for our
- 19:31policies? And I would say that the on and
- 19:35they they're going to be friendlier, but we'll see how
- 19:39how friendly at the end of the day, because if you actually
- 19:41looked at the legislature, they don't let they don't like how
- 19:44they see that the citizens don't like health plans.
- 19:47They blame everything on the health plan.
- 19:49So therefore MA is and you've got not for private health
- 19:53systems. So blaming the MA.
- 19:56So you've got like two groups that are now like dumping on MA
- 19:59and it'll be interesting to see where it all comes out.
- 20:01I think when? Doctor Oz wakes up in the
- 20:02morning after he takes whatever supplements he take.
- 20:06He thinks. To himself how can I grow the MA
- 20:07business for the world and so I think that they're going to make
- 20:10stars easier more plans will be in four plus star plans I think
- 20:14they're going to like. Besides.
- 20:16You not to healthcare like in general put more money into the
- 20:18system and let it and want it to grow I think they're going to
- 20:21pay for food as medicine because that's a RFK junior idea and I
- 20:26think that at the end of this their Medicare Advantage will be
- 20:28quite a bit bigger than it will be yeah so you're.
- 20:31Optimistic on that? Well, I just.
- 20:33Wake up in the morning thinking that every Republican is wearing
- 20:35AT shirt that says I heart MA because they like the
- 20:37privatization of Medicare and they would have liked Zafra
- 20:40going to be bigger and so while they're making any.
- 20:43Is saying that like the voter base, it doesn't square anymore,
- 20:46that they would continue. I know that's the.
- 20:47Confusing part because everything's diffusing, but I
- 20:49think that at the end of the day, like Republicans love MA
- 20:51and that's just one of those things that is like it's a good
- 20:54it's a it's a dogmatic statement.
- 20:56And I think they don't like they're sort of burden of the
- 20:59current stars program of all the complexity that we put in it as
- 21:03A to make it better. So I think they're going to let
- 21:05it grow with the asterisk being an out of the health care
- 21:08concerns and because of their coding practices and they're
- 21:10going to get a bunch of skirt and the vaccine.
- 21:12Step like what's what's your reaction to that?
- 21:14Like how damaging or not do you think it will be?
- 21:19I I think it's. Well, I think it's actually very
- 21:22damaging. But I do think, you know, for
- 21:25example, we're actually in a vaccine administration company
- 21:28that's doing very well. But last year when you had
- 21:33states like Texas and Oklahoma, you had several, you know, I
- 21:39would say towns that did not embrace vaccines.
- 21:42And those towns ended up getting the needles.
- 21:45And then more, you know, more children went to the hospital.
- 21:48You had a couple kids die. Our vaccines administration for
- 21:52measles went up 50% last year. So I think that that's all it
- 21:56takes. And I do think you mostly have
- 21:58rational physicians. I think physicians are, you
- 22:02know, saying that vaccines were good in general, you know, in
- 22:05most of the list is there. Obviously but our our
- 22:08pediatrician won't even recommend a non vaccine
- 22:11providing Dr. You don't want to take vaccine like good luck.
- 22:14Vaccines are the. Safest intervention that exists
- 22:17in healthcare on the Earth, period.
- 22:18They work. You should get them, you should
- 22:20recommend them. I give them to people, and I
- 22:23think that most people actually believe that and we'll get them.
- 22:26I think it's sad that we're making them harder to get.
- 22:29I think it's sad that now they won't always be covered so you
- 22:32don't have to pay a pocket. But my 84 year old aunt just
- 22:35sent me a picture from this morning from Safeway where she
- 22:38was getting her COVID shot. I mean, she bought herself a
- 22:40donut and it was a good day for her.
- 22:41And so I'm happy about that. Great.
- 22:44Bob and Annie, thank you very much.
- 22:51Here's a conversation with venture capitalist Vinod Khosla.
- 22:54I sat down with Naima Raza, my Deus Ex Medicina Co host, to
- 22:58talk with Vinod about all the major themes in health.
- 23:03You've been making. Predictions about healthcare
- 23:05since I think longer than we've been alive.
- 23:09You know, the last long term prediction I did was in 2016,
- 23:13about 10 years ago and I would say we are well ahead of the
- 23:17schedule. I predicted 8 three-year cycles
- 23:21of innovation. So I had assumed 3 year cycles
- 23:27of significant innovation. That's 25 years.
- 23:32So so I figured 2040, but I think things are happening much
- 23:38faster than I ever imaged one of the.
- 23:40Things you've said is that innovation and AI is not going
- 23:43to come from the giants, it's going to come from start up
- 23:46because you've held strong to that.
- 23:47So when you look at it, who do you?
- 23:49Who do you? See, as the kind of Tesla you're
- 23:52famously, you know, you're a big fan of what Elon Musk has, not
- 23:55an electric vehicle. Who do you see as the Tesla of
- 23:57AI and then the Tesla of healthcare?
- 24:00Well, I don't. Think the Tesla of AI has
- 24:03emerged, OK, but it will emerge. So if you look at healthcare
- 24:10companies today, and I speak to all of them, I speak to their
- 24:13boards and executives, they are looking at things incrementally.
- 24:19And so yes, and I'm very glad they'll all introduce a bridge.
- 24:24One of our companies so great, but that's taking current system
- 24:32and incrementally adding AI to it and automating.
- 24:39There was a board I was speaking to recently.
- 24:41I said clearly do that and you can take costs out and improve
- 24:45efficiency in fact just like a bridge does.
- 24:50The real company in the UK called Tortoise and they just
- 24:54announced a major study with the NHS with doctors adapting their
- 25:01system. It is pretty stunning.
- 25:04Got 25% more actual FaceTime with patients.
- 25:12And so my tweet was so suddenly they've increased the doctor
- 25:16supply in all of the UK by 25%. That's a pretty big deal.
- 25:22It would have taken them two decades to do that any other
- 25:26way. But that's not the key question.
- 25:31The key question is if you believe all healthcare
- 25:35expertise. It doesn't matter whether you're
- 25:37talking about primary care doc, mental health therapist, a
- 25:41psychiatrist, an oncologist, A gastroenterologist, a physical
- 25:46therapist, a health coach, all of it was free.
- 25:50How would you design A healthcare system that's a very
- 25:54different system than today's system in?
- 25:58The venture capitalists have been throwing themselves against
- 26:01those rocks for gener or decades was sort of like there are
- 26:05constraints. Now there were constraints and
- 26:08automotive too, lots of regulation, lots of standards
- 26:12and what it takes is not rocks. What it takes is a great
- 26:20entrepreneur like Ilan did that and you don't.
- 26:23You don't look across and see that.
- 26:24Yeah, you say it hasn't yet. I.
- 26:26Haven't seen a person fundamentally trying to redesign
- 26:31the system on an assumption that all expertise costs zero.
- 26:36So you'd never ration access to an oncologist or a neurologist.
- 26:41You'd provide it upfront, day one first conversation because
- 26:46it's the same cost as a nurse. Do you think that?
- 26:48Might happen outside of the United States because I mean,
- 26:51one of the things that we've been hearing from people today
- 26:53is how the US lagging behind on healthcare not just from
- 26:56alchemy, but I think it. Might it might happen in the
- 26:59developing world? Now developing world costs are
- 27:03very low for expertise, so in a doctor in India doesn't cost
- 27:08very much, but it might happen there.
- 27:14I do think I originally, when I first wrote my blog in 2016,
- 27:20taught the uninsured population in the US, which was.
- 27:26Back then about 40 million people, pretty good side would
- 27:29be the right place to start because they had no other
- 27:33starting news. But instead we took a lot of
- 27:36those people away. I wanted to pose like what to me
- 27:41is like the existential question of this conference, right?
- 27:45We, we've spoken before at this River Valley AI Summit, which
- 27:48sort of takes as the premise that the smartest companies will
- 27:52be the general purpose models. And obviously you are the first
- 27:56venture investor in open AI, You're highly aligned with open
- 28:00AI, but you also have health investments, obviously many of
- 28:02them as well. Like what's your heuristic?
- 28:06How do you decide this is the domain of the juggernaut of open
- 28:11AI of the general purpose model versus say it's a health
- 28:14specific challenge? In a lot of areas, I'd like to
- 28:19joke every time Open AI releases the model, half of the wise
- 28:24batch goes out of business that just the standard paragraph.
- 28:29So I think if you're a starter interested in help, they're
- 28:32interested in, they're interested in help, they're
- 28:34interested in help, they're interested in a lot of different
- 28:37areas and they should be and all the major guys will do all these
- 28:41things. But what has happened
- 28:43traditionally is because there's not one model provider and you
- 28:50can easily move between model providers, question will be on
- 28:57top of the mark. We are open AI or Entropic or
- 29:02Google will have an advantage. So what value can they add or
- 29:07the specific application now really want to put up pull up a
- 29:13patient's record out of Epic before giving advice.
- 29:19Tricky question. I couldn't say never, but it's
- 29:23not looking night likely that they're going to write you a
- 29:26prescription today. And I think that many, many
- 29:31things you can do that would be startup territory.
- 29:38So I think they'll be great start-ups.
- 29:41I don't care what open AI does. It doesn't compete with sword
- 29:45health. Sword health is doing physical
- 29:48therapy at a level and growing faster than I would ever imagine
- 29:53any healthcare start up with the exception of a bridge which is
- 29:58doing really really well. Fortunate to be investors in
- 30:03both, but there is going to be value add.
- 30:08Physical therapy is one of those where in the eyes watching you
- 30:11ain't guiding you in handling billability.
- 30:15And now people like Amazon taking care of the fact that
- 30:20they'll bill your insurance will open AI do that, Google do that?
- 30:25Possibly, yeah. We we're going to ask you what?
- 30:27Companies you like outside of your portfolio of a note, but I
- 30:30I do want on this idea outside of AI, you're seeing obviously
- 30:34massive tailwinds around GLP one.
- 30:37How has that and the willingness of consumers to pay out of
- 30:41pocket? Change your.
- 30:43Thesis on healthcare if at all I.
- 30:45Think consumers have always been willing to pay if it's cost
- 30:50effective, not the insurance price.
- 30:53This is the only market where buying one of something is
- 30:57cheaper than buying 100,000 of something.
- 31:00That's the the unfortunate part of the healthcare system.
- 31:05But GLP 1 is a good example. But you know, five years ago,
- 31:11people, four years ago people said people will never pay out
- 31:15of pocket for cardiac care. A live core has 300,000
- 31:19subscribers and retention is 90 some percent year to year.
- 31:25The cardiac patients died. But other than that, incredible
- 31:31retention, incredible engagement.
- 31:33The typical patient is taking 6 ECD's a month.
- 31:39You'd be lucky if you're in the best healthcare system and got
- 31:436CC DS in two years, right? That's per month.
- 31:48Now they can look at your, they have the data, millions and
- 31:53millions of PC DS per month, usually in context and they can
- 31:58do something like say, hey, you're taking, by the way, this
- 32:05doesn't even take FDA approval. We're watching your EC GS
- 32:09taking, you're taking them more than once a week.
- 32:13Something's changing. Come on in, talk to us about,
- 32:18talk to our cardiologist. So adjust an alert saying you
- 32:23need to check in. It's incredibly valuable.
- 32:26And the number of visits to emergency rooms goes through the
- 32:31floor. So that's an example of
- 32:34something the big model companies aren't going to do.
- 32:37They aren't going to take that many CDs and provide coaching
- 32:40around that. So the the sword is an example.
- 32:44That's an example. There's plenty of examples like
- 32:48that when. You think about, you know, your
- 32:51own health or you know, recommending to your friends.
- 32:55Like how much do you think all all the things you're doing are
- 32:58recommended by a doctor or you think there is like everything?
- 33:01I do is recommended by ChatGPT and then I check with the
- 33:05doctors for safety like is it OK you're since you're being
- 33:09sincere? I am being sincere.
- 33:12Your doctor's. Like Oh my God, why are you
- 33:14bringing this to me? Or I mean, just ask them.
- 33:18And if they disagree with chat, TPDI asked another doctor.
- 33:23Because the SO here I believe. There's a so let me give you a.
- 33:28Recent study out of Stanford, Arnie Milstein who's probably
- 33:35one of the better known professors in the country on
- 33:39quality of medical care did a multi centre study.
- 33:45Human doctor performance for this was for complex disease
- 33:48diagnosis at pretty fancy institutions like Stanford.
- 33:52Human accuracy in complex disease diagnosis for 73%.
- 33:59That means 27% of the patients of complex disease.
- 34:03This is not you got the flu, got the wrong diagnosis or a
- 34:07suboptimal diagnosis. AI, which is out-of-the-box, It
- 34:14wasn't really tuned for medical practice.
- 34:17What's 88%? And then they gave the AI to the
- 34:22doctors. The doctors improved, but from
- 34:2573% to 76% and they degraded the AI from 88 to 76, right?
- 34:31And that is the reality of the attachable.
- 34:34RAW you don't want to like have the doctor mess.
- 34:37This is why if if a doctor agree disagrees with ChatGPT, you
- 34:43should ask another doctor and another doctor and another
- 34:45doctor. ChatGPT?
- 34:46What happened when they gave the the GPT the doctor?
- 34:52If they couldn't use it, you know it's who you put in charge.
- 34:58If the doctors in charge, they will introduce their biases.
- 35:03In one of the biggest biases, the doctor had this recent C
- 35:07bias. Which patient did they see
- 35:09recently and what did they have? Do you think though?
- 35:12There's by the way. Plenty of studies to show if the
- 35:15New York Times mentioned the disease, it's diagnosis in the
- 35:19country goes way up. It's this recency bias and.
- 35:24AI has some recency bias surely Building it's hopefully.
- 35:28Not but yeah, that's right. When you look at the future, one
- 35:32of the things when John Shaw was here earlier today talking about
- 35:34Hippocratic AI and you know, if when asked how many doctors will
- 35:38there be in the in the world in 2040, he said they'll be admin
- 35:42doctors as people. The clinicians will all be
- 35:44artificial intelligence agent. You know Tom Hill was here from
- 35:48aura and talked about I asked him if the ring would one day
- 35:52connect to an agent and he said that he and Lynjol had been
- 35:54talking about that is this is there going to be a fungal and
- 35:57Healthcare is how close were you here's.
- 35:59His Healthcare is large span. There's four major chunks to it.
- 36:06One is doctors and expertise outside the hospital.
- 36:10Another slice is drugs. Another slice is testing and MRI
- 36:15and imaging and blood tests and X-rays that is in hospital care.
- 36:20So roughly say each one is a trillion dollars.
- 36:25The the first portion which medical expertise is going to be
- 36:31better in an AI? No question if we let it get
- 36:35there, the AMA is completely opposed to AI practicing
- 36:40medicinal prescribing because for a dollar they lose $150.00
- 36:46physician visit in the clinic. That's the reality, right?
- 36:52I've talked to the the he stepped down now the president,
- 36:55the MAA half a dozen times and they always avoid the topic.
- 37:01But there's going to be easy ways.
- 37:03I was just talking to Doctor Oz and I said, so how many people
- 37:09familiar with Medicare Advantage?
- 37:11A few hats. The odd thing about medical
- 37:16Medicare Advantage, if you talk to companies like Humana that
- 37:21are some of the largest in Medicare Advantage, they spend I
- 37:25would say 80% of their effort in risk scoring a patient up not on
- 37:33medical care. They provide almost no care.
- 37:37And now what I told Doctor Oz is Medicare Advantage should have
- 37:41an AI score to the patient. If a provider like Humana
- 37:47disagrees with the scoring, they can appeal it to a human.
- 37:52But then if they're wrong, they pay for it.
- 37:56It's a simple I did you get the read that they are going to do?
- 38:01More in Medicare Advantage or less or what was your read?
- 38:03I think there's definitely a lot.
- 38:04Of interest in doing that kind of thing but why would you let
- 38:09the the fox in the hen house and let them say how complex is
- 38:13who's this patient so pay me more.
- 38:16What is your outlook on what the Trump?
- 38:18Administration has done healthcare so far.
- 38:20What kind of grade would you get LA?
- 38:22Through A well, I think. RFK Yeah, I know.
- 38:26If there's a grade low enough, what comes?
- 38:30I asked. F minus.
- 38:33Minus. Do you think he's going to ask?
- 38:39I won't comment on that. I don't know the inside
- 38:41politics. He obviously cut a deal with
- 38:44Trump during the election, which is a sad state of affairs where
- 38:49our health portfolio and vaccine policies are auctioned off
- 38:55during an election. But they are doing a lot of good
- 39:00things. For example, I would say Doctor
- 39:07Odds has a very sensible view of how to use AI.
- 39:12In fact, I first wrote 100 page document on the transformation
- 39:17of medicine in 2016 called 20% Doctor Included it's 100 page
- 39:23PDF. And I have an e-mail from Doctor
- 39:26Odds in 2016 commenting on MY108810 years ago.
- 39:33So he's very interested in that kind of thing.
- 39:37I think the FDA is very interested.
- 39:41The new head of AI at the FDA, Shantu Shantanu, is really very
- 39:48interested in more adoption up here and the CDC any.
- 39:53Thoughts on what's happening at the CDC?
- 39:55Yeah, I have no exposure to the. Cdci can not to deal with that
- 40:00side of. Put some of this in the context
- 40:02of the. Competition with China,
- 40:04obviously that's been an important issue for you.
- 40:06How do you scale? You know, we were hearing
- 40:08earlier today certainly, you know, developing drugs.
- 40:11China is becoming in some ways this becomes the dominant place
- 40:14all our. Companies trying to go to China
- 40:16get first in humans is easy. Drug manufacturing is easy it
- 40:22there's still decent regulation, but trials are easier.
- 40:26The US needs to loosen up. It's not a big deal.
- 40:29It can be developed in China and then we can pay for it.
- 40:31What's what's your sense of how this plays out?
- 40:34Well, I don't think we will loosen up here.
- 40:38So that's unfortunate. Fast forward now, there's
- 40:42another path, right? AI based drug design can be done
- 40:48pretty differently. Not for all diseases, you know,
- 40:53a vaccine is a vaccine for everybody, but there's a lot of
- 40:58diseases. So for example, in sickle cell
- 41:01anemia, gene therapy can be pretty well done.
- 41:06Here we we have a company that's treated its second patient.
- 41:10It's public data, completely cured of sickle cell, that kind
- 41:16of precision. Preventative medicine that seems
- 41:18to be taking off in the United States.
- 41:20Do you think like Fast forward, do you still think a time
- 41:24horizon for prediction should be 40 years or should it now be
- 41:26like 10 years worth? You can't predict past five
- 41:29years. In technology, application of
- 41:34technology is a different metrics especially if it has a
- 41:37regulatory constraint. That's why I think it's
- 41:40completely up to grabs how aggressive or regressive with
- 41:44the administration beyond hopeful this administration in
- 41:48its quest to have pure regulation will will be much
- 41:53more aggressive in adapting AI and new technologies in this
- 41:58country and what are three things that you.
- 42:00Think American policy makers, regulators should be doing to
- 42:03that? America up to beat China and
- 42:05well, first assume. AI will be smarter than humans
- 42:09in almost every single area. No, don't.
- 42:12Aside, don't side. With the AMA as a consumer,
- 42:15right? Because the government is such a
- 42:20spender, large spender in healthcare have a process for
- 42:26safely because safety is no matter what you think and no
- 42:32matter what RFK thinks what safety is.
- 42:36Safety is critical in healthcare, but you can still do
- 42:40safety in a lot of trials. I mean, look at the medicine.
- 42:48The fundamental premise of medicine is the Hippocratic
- 42:52Oath, which every doctor takes, and it's mathematically wrong.
- 42:57It's the dumbest rule to have. If you can save 10 lives and do
- 43:02a little harm and save 10,000 lives, won't do it.
- 43:07You want the Bayesian, not the. Hypocrite here, but.
- 43:11You know, taking a progressive, logical first principles view of
- 43:15what is the right thing to do, that's the right thing.
- 43:20Great. Well, we can talk all day,
- 43:21Vinod. Khosla, thank you so much.
- 43:23Great. Thank you.